Hymovis, a highly effective treatment for knee osteoarthritis, offers one of the best injectable solutions to reduce joint discomfort. By acting as a lubricant within the knee joint, the gel creates a shock-absorbing “cushion,” alleviating pain and improving overall comfort during daily activities. It’s also beneficial after knee replacement surgery, accelerating recovery and easing post-surgery discomfort.
For patients suffering from knee osteoarthritis, finding a solution that alleviates pain and restores mobility is crucial. Buy Hymovis – it provides long-lasting relief by improving joint lubrication and functionality, addressing the limitations of conventional treatments like physical therapy or medications. This hyaluronic acid injection enhances joint function, reduces friction, and boosts comfort, making it an excellent choice for those dealing with knee osteoarthritis.
Hymovis is an advanced hyaluronic acid-based injection designed to relieve knee osteoarthritis symptoms by improving joint lubrication and function. Its special formulation enhances joint elasticity and viscosity, helping absorb shock and reduce friction. The result is a significant reduction in pain and improvement in mobility, making Hymovis a long-term solution for those suffering from knee osteoarthritis. Hymovis is also effective for use in the hip and shoulder joints, providing versatile relief for various osteoarthritis conditions.
Hymovis is manufactured by Fidia Pharmaceuticals, a renowned company based in Italy.
Hymovis products contain ultra-pure hyaluronic acid (hyaluronan), a key ingredient that provides essential cushioning and lubrication to the joints. This hyaluronan is dissolved in physiological saline to form the HYADD4 hydrogel, produced through a patented process. The saline solution ensures stability and effective absorption, enhancing the hydrogel’s ability to protect and support the joint.
Hymovis is available in pre-filled syringes for single-use, ensuring ease of application and sterility. The standard dosage form is typically 24 mg/3 ml.
Hymovis can provide relief from knee osteoarthritis pain for up to 6 months. The exact duration of pain relief may vary depending on the patient’s joint condition, pain intensity, and medical history. Typically, relief starts within 24 to 36 hours after the injection.
Before treatment, a consultation with a healthcare professional is essential to evaluate the patient’s health, the severity of osteoarthritis, and any potential contraindications. The consultation is also an opportunity to discuss potential side effects and recovery guidelines.
Avoid using disinfectants containing quaternary ammonium salts, as they may cause the hydrogel to precipitate. Hymovis should not be used in the presence of joint effusions. Patients should also avoid high-impact activities such as running, lifting heavy weights, or standing for long periods following injections.
Maintain communication with the healthcare provider regarding any complications or concerns.
Overall, Hymovis is a safe and effective injectable treatment offering fast results and long-lasting pain relief when administered by an experienced medical professional. But as with any injectable, side effects may occur after Hymovis injections. The most common reactions are temporary and typically resolve within a few days:
Patients should inform their healthcare provider if they experience severe reactions such as allergic responses, difficulty breathing, irregular heartbeat, or intense pain.
Hymovis should not be used by individuals with:
Hymovis products are strictly available to licensed medical professionals. This ensures that the products are applied safely and effectively, with the expertise of trained professionals who understand the nuances of osteoarthritis treatments.
To maintain the highest standards of authenticity and quality, it is essential for professionals to purchase orthopedic injections from reputable and trusted suppliers, such as NuDerma Supply’s online store, which guarantees the integrity of the products and ensures they are sourced from reliable, authorised distributors.
Yes, Hymovis is manufactured under strict laboratory conditions, ensuring its safety and efficacy. The hyaluronan used is derived from a regulated fermentation process, purified extensively, and free from pyrogens, chemical cross-linking agents, or animal proteins.
Yes, Hymovis is FDA-approved for the treatment of knee osteoarthritis.
Hymovis is typically administered in two injections, spaced one week apart.
Both Hymovis and Durolane use hyaluronic acid to treat knee osteoarthritis, but they differ in their administration protocols. Durolane typically requires a single injection, while Hymovis involves a two-injection regimen, administered one week apart.
Monovisc is classified as a moderate molecular weight hyaluronic acid and is cross-linked at the time of injection. Hymovis, on the other hand, is considered low molecular weight and is non-cross-linked at the time of injection.
Join our newsletter to receive latest news and offers
Medicle MD Ltd
Reg. Number: 14317237
Address: 27 Old Gloucester Street,
WC1N 3AX London,
United Kingdom